277 related articles for article (PubMed ID: 26012253)
1. Structure-inhibition relationship of podophyllotoxin (PT) analogues towards UDP-glucuronosyltransferase (UGT) isoforms.
Qi JQ; Cao YF; Sun XY; Hong M; Fang ZZ; Meng DL; Sun DX
Pharmazie; 2015 Apr; 70(4):239-43. PubMed ID: 26012253
[TBL] [Abstract][Full Text] [Related]
2. Enantioselective inhibition of carprofen towards UDP-glucuronosyltransferase (UGT) 2B7.
Fang ZZ; Wang H; Cao YF; Sun DX; Wang LX; Hong M; Huang T; Chen JX; Zeng J
Chirality; 2015 Mar; 27(3):189-93. PubMed ID: 25502512
[TBL] [Abstract][Full Text] [Related]
3. Herb-drug interaction prediction based on the high specific inhibition of andrographolide derivatives towards UDP-glucuronosyltransferase (UGT) 2B7.
Ma HY; Sun DX; Cao YF; Ai CZ; Qu YQ; Hu CM; Jiang C; Dong PP; Sun XY; Hong M; Tanaka N; Gonzalez FJ; Ma XC; Fang ZZ
Toxicol Appl Pharmacol; 2014 May; 277(1):86-94. PubMed ID: 24631340
[TBL] [Abstract][Full Text] [Related]
4. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
[TBL] [Abstract][Full Text] [Related]
5. Biotransformation of baicalin to baicalein significantly strengthens the inhibition potential towards UDP-glucuronosyltransferases (UGTs) isoforms.
Teng Y; Nian H; Zhao H; Chen P; Wang G
Pharmazie; 2013 Sep; 68(9):763-7. PubMed ID: 24147345
[TBL] [Abstract][Full Text] [Related]
6. Gossypol exhibits a strong influence towards UDP-glucuronosyltransferase (UGT) 1A1, 1A9 and 2B7-mediated metabolism of xenobiotics and endogenous substances.
Zhang YS; Yuan J; Fang ZZ; Tu YY; Hu CM; Li G; Wang L; Deng JP; Yao JJ; Li HR
Molecules; 2012 Apr; 17(5):4896-903. PubMed ID: 22543504
[TBL] [Abstract][Full Text] [Related]
7. Drug interaction study of natural steroids from herbs specifically toward human UDP-glucuronosyltransferase (UGT) 1A4 and their quantitative structure activity relationship (QSAR) analysis for prediction.
Xu M; Dong P; Tian X; Wang C; Huo X; Zhang B; Wu L; Deng S; Ma X
Pharmacol Res; 2016 Aug; 110():139-150. PubMed ID: 27208893
[TBL] [Abstract][Full Text] [Related]
8. Structure-inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs).
Fang ZZ; Cao YF; Hu CM; Hong M; Sun XY; Ge GB; Liu Y; Zhang YY; Yang L; Sun HZ
Toxicol Appl Pharmacol; 2013 Mar; 267(2):149-54. PubMed ID: 23306165
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of UDP-glucuronosyltransferases (UGTs) by tetraiodothyronine (T4) and triiodothyronine (T3).
Chen DW; Du Z; Zhang CZ; Zhang WH; Cao YF; Sun HZ; Zhu ZT; Yang K; Liu YZ; Zhao ZW; Fu ZW; Gu WQ; Yu Y; Fang ZZ
Xenobiotica; 2018 Mar; 48(3):250-257. PubMed ID: 28285550
[TBL] [Abstract][Full Text] [Related]
10. Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin.
Hanioka N; Ozawa S; Jinno H; Ando M; Saito Y; Sawada J
Xenobiotica; 2001 Oct; 31(10):687-99. PubMed ID: 11695848
[TBL] [Abstract][Full Text] [Related]
11. Acitretin exhibits inhibitory effects towards UDP-glucuronosyltransferase (UGT)1A9-mediated 4-methylumbelliferone (4-MU) and propofol glucuronidation reaction.
Yu ML; Yang Y; Wang CM; Zhang MM; Bai MC; Guo YL
Pharmazie; 2013 Jun; 68(6):449-52. PubMed ID: 23875253
[TBL] [Abstract][Full Text] [Related]
12. In vitro glucuronidation of the primary metabolite of 10-chloromethyl-11-demethyl-12-oxo-calanolide A by human liver microsomes and its interactions with UDP-glucuronosyltransferase substrates.
Liu X; Sheng L; Zhao M; Mi J; Liu Z; Li Y
Drug Metab Pharmacokinet; 2015 Feb; 30(1):89-96. PubMed ID: 25760535
[TBL] [Abstract][Full Text] [Related]
13. Inhibition potential of UDP-glucuronosyltransferases (Ugts) 1A isoforms by the analogue of resveratrol, bakuchiol.
Dong DG; Zhang Y; Zhang SL; Lv J; Guo EM; Fang ZZ; Cao YF
Pharmazie; 2014 Jan; 69(1):60-3. PubMed ID: 24601226
[TBL] [Abstract][Full Text] [Related]
14. In vitro selective inhibition of human UDP-glucuronosyltransferase (UGT) 1A4 by finasteride, and prediction of in vivo drug-drug interactions.
Lee SJ; Park JB; Kim D; Bae SH; Chin YW; Oh E; Bae SK
Toxicol Lett; 2015 Jan; 232(2):458-65. PubMed ID: 25448279
[TBL] [Abstract][Full Text] [Related]
15. Probe substrate and enzyme source-dependent inhibition of UDP-glucuronosyltransferase (UGT) 1A9 by wogonin.
Chengcheng G; Rui X; Tianheng M; Wei Y; Liqun P
Afr Health Sci; 2013 Sep; 13(3):551-5. PubMed ID: 24250287
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the drug-drug interactions potential of erlotinib and gefitinib via inhibition of UDP-glucuronosyltransferases.
Liu Y; Ramírez J; House L; Ratain MJ
Drug Metab Dispos; 2010 Jan; 38(1):32-9. PubMed ID: 19850672
[TBL] [Abstract][Full Text] [Related]
17. Ganoderic acid B's influence towards the therapeutic window of trifluoperazine (TFP).
Guo J; Ni C; Liu X; Liu T
Afr Health Sci; 2015 Mar; 15(1):146-9. PubMed ID: 25834543
[TBL] [Abstract][Full Text] [Related]
18. Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors.
Walsky RL; Bauman JN; Bourcier K; Giddens G; Lapham K; Negahban A; Ryder TF; Obach RS; Hyland R; Goosen TC
Drug Metab Dispos; 2012 May; 40(5):1051-65. PubMed ID: 22357286
[TBL] [Abstract][Full Text] [Related]
19. Strong inhibition of celastrol towards UDP-glucuronosyl transferase (UGT) 1A6 and 2B7 indicating potential risk of UGT-based herb-drug interaction.
Zhang YS; Tu YY; Gao XC; Yuan J; Li G; Wang L; Deng JP; Wang Q; Ma RM
Molecules; 2012 Jun; 17(6):6832-9. PubMed ID: 22669039
[TBL] [Abstract][Full Text] [Related]
20. Chirality Influence of Zaltoprofen Towards UDP-Glucuronosyltransferases (UGTs) Inhibition Potential.
Jia L; Hu C; Wang H; Liu Y; Liu X; Zhang YY; Li W; Wang LX; Cao YF; Fang ZZ
Chirality; 2015 Jun; 27(6):359-63. PubMed ID: 25903196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
